JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takeshige, C.
Right arrow Articles by Volle, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeshige, C.
Right arrow Articles by Volle, R. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 146, Issue 3, 335-343, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


MODIFICATION OF GANGLIONIC RESPONSES TO CHOLINOMIMETIC DRUGS FOLLOWING PREGANGLIONIC STIMULATION, ANTICHOLINESTERASE AGENTS AND PILOCARPINE

Chifuyu Takeshige 1 and Robert L. Volle 1

1 Department of Pharmacology, Schools of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

An analysis was made of the alterations in the responses to drugs produced by repetitive stimulation of the preganglionic nerve of the superior cervical ganglia of cats. A sustained, low amplitude depolarization of the ganglia, which was sensitive to blockade by atropine, was observed following repetitive preganghionic stimulation, the administration of anticholinesterase agents, and the injection of pilocarpine. Marked changes in the ganglionic responses to acetylcholine (ACh) and methacholine (MCh) occurred when the choline esters were administered during the depolarization evoked by the above procedures.

The initial period of depolarization produced by ACh (D potential) was depressed after preganglionic stimulation at a time when the "early" postganglionic response (ER) to ACh was enhanced. Similar results were obtained in ganglia treated with large doses of anticholinesterase agents or pilocarpine. Small doses of atropine prevented the depression of the D potential but had no effect on the ER to ACh. The ganghionic hyperpolarization (H potential) evoked by ACh or MCh was enhanced in hanglia conditioned by preganglionic stimulation, the anticholinesterase agents, or piocarpine. On the other hand, the late occurring depolarization (LD potential) evoked by ACh or MCh was depressed under these conditions. The "late" postganglionic response (LR) to ACh and MCh was enhanced by the anticholinesterase agents and preganglionic stimulation but not by pilocarpine. Atropine blocked the H and LD potentials and the LR to the choline esters.

Although the findings demonstrate a parallelism between depolarization of atropine-sensitive cholinoceptive sites and enhanced postganglionic responses to ganglionic stimulating agents, the failure of atropine to prevent the development by preganglionic stimulation of enhanced responses to ACh argues against a cause and effect relationship. The alterations occurring in conditioned ganglia of the contours of the ganglionic potentials evoked by ACh and MCh are explained provisionally on the basis of persistent ganglionic depolarization of atropine-sensitive sites.

Accepted on September 9, 1964




This article has been cited by other articles:


Home page
ScienceHome page
A. J. Pappano and R. L. Volle
Lithium's Failure to Replace Sodium in Mammalian Sympathetic Ganglia
Science, April 1, 1966; 152(3718): 85 - 87.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.